On 02 February 2017
Glenmark Pharmaceuticals announced that a meeting of the Board of Directors will be held on 02 February 2017, to consider and approve the Company's Unaudited Financial Statements for the Third Quarter and Nine months ended 31 December 2016 (Q3).Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
